175 related articles for article (PubMed ID: 2543771)
1. The temperature sensitivity of the Sabin type 3 vaccine strain of poliovirus: molecular and structural effects of a mutation in the capsid protein VP3.
Minor PD; Dunn G; Evans DM; Magrath DI; John A; Howlett J; Phillips A; Westrop G; Wareham K; Almond JW
J Gen Virol; 1989 May; 70 ( Pt 5)():1117-23. PubMed ID: 2543771
[TBL] [Abstract][Full Text] [Related]
2. An assembly defect as a result of an attenuating mutation in the capsid proteins of the poliovirus type 3 vaccine strain.
Macadam AJ; Ferguson G; Arnold C; Minor PD
J Virol; 1991 Oct; 65(10):5225-31. PubMed ID: 1654440
[TBL] [Abstract][Full Text] [Related]
3. Mutations in the poliovirus P1 capsid precursor at arginine residues VP4-ARG34, VP3-ARG223, and VP1-ARG129 affect virus assembly and encapsidation of genomic RNA.
Ansardi DC; Luo M; Morrow CD
Virology; 1994 Feb; 199(1):20-34. PubMed ID: 8116243
[TBL] [Abstract][Full Text] [Related]
4. In vitro phenotypic markers of a poliovirus recombinant constructed from infectious cDNA clones of the neurovirulent Mahoney strain and the attenuated Sabin 1 strain.
Kohara M; Omata T; Kameda A; Semler BL; Itoh H; Wimmer E; Nomoto A
J Virol; 1985 Mar; 53(3):786-92. PubMed ID: 2983090
[TBL] [Abstract][Full Text] [Related]
5. Determinants of attenuation and temperature sensitivity in the type 1 poliovirus Sabin vaccine.
Bouchard MJ; Lam DH; Racaniello VR
J Virol; 1995 Aug; 69(8):4972-8. PubMed ID: 7609067
[TBL] [Abstract][Full Text] [Related]
6. Covariance of lowered capacity to induce interferon in human leukocytes and temperature sensitivity of type 3 poliovirus.
Hovi T; Pitkäranta A; Macadam A; Minor P; Almond J
J Interferon Res; 1991 Apr; 11(2):105-10. PubMed ID: 1714485
[TBL] [Abstract][Full Text] [Related]
7. A Single Amino Acid Substitution in Poliovirus Nonstructural Protein 2CATPase Causes Conditional Defects in Encapsidation and Uncoating.
Asare E; Mugavero J; Jiang P; Wimmer E; Paul AV
J Virol; 2016 Jul; 90(14):6174-6186. PubMed ID: 27076638
[TBL] [Abstract][Full Text] [Related]
8. Genetic basis of attenuation of the Sabin type 3 oral poliovirus vaccine.
Westrop GD; Wareham KA; Evans DM; Dunn G; Minor PD; Magrath DI; Taffs F; Marsden S; Skinner MA; Schild GC
J Virol; 1989 Mar; 63(3):1338-44. PubMed ID: 2536836
[TBL] [Abstract][Full Text] [Related]
9. Attenuated poliovirus strain as a live vector: expression of regions of rotavirus outer capsid protein VP7 by using recombinant Sabin 3 viruses.
Mattion NM; Reilly PA; DiMichele SJ; Crowley JC; Weeks-Levy C
J Virol; 1994 Jun; 68(6):3925-33. PubMed ID: 8189529
[TBL] [Abstract][Full Text] [Related]
10. A recombinant virus between the Sabin 1 and Sabin 3 vaccine strains of poliovirus as a possible candidate for a new type 3 poliovirus live vaccine strain.
Kohara M; Abe S; Komatsu T; Tago K; Arita M; Nomoto A
J Virol; 1988 Aug; 62(8):2828-35. PubMed ID: 2839704
[TBL] [Abstract][Full Text] [Related]
11. Reversion of the attenuated and temperature-sensitive phenotypes of the Sabin type 3 strain of poliovirus in vaccinees.
Macadam AJ; Arnold C; Howlett J; John A; Marsden S; Taffs F; Reeve P; Hamada N; Wareham K; Almond J
Virology; 1989 Oct; 172(2):408-14. PubMed ID: 2552655
[TBL] [Abstract][Full Text] [Related]
12. Genetic analysis of the attenuation phenotype of poliovirus type 1.
Omata T; Kohara M; Kuge S; Komatsu T; Abe S; Semler BL; Kameda A; Itoh H; Arita M; Wimmer E
J Virol; 1986 May; 58(2):348-58. PubMed ID: 3009852
[TBL] [Abstract][Full Text] [Related]
13. Development of candidates for new type 2 and type 3 oral poliovirus vaccines.
Kohara M; Abe S; Yoshioka I; Nomoto A
Dev Biol Stand; 1993; 78():141-8. PubMed ID: 8388824
[TBL] [Abstract][Full Text] [Related]
14. Studies on the attenuation phenotype of polio vaccines: poliovirus RNA polymerase derived from Sabin type 1 sequence is temperature sensitive in the uridylylation of VPg.
Paul AV; Mugavero J; Yin J; Hobson S; Schultz S; van Boom JH; Wimmer E
Virology; 2000 Jun; 272(1):72-84. PubMed ID: 10873750
[TBL] [Abstract][Full Text] [Related]
15. Formation of poliovirus-like particles by recombinant baculoviruses expressing the individual VP0, VP3, and VP1 proteins by comparison to particles derived from the expressed poliovirus polyprotein.
Bräutigam S; Snezhkov E; Bishop DH
Virology; 1993 Feb; 192(2):512-24. PubMed ID: 8380663
[TBL] [Abstract][Full Text] [Related]
16. Correlation of mutations and recombination with growth kinetics of poliovirus vaccine strains.
Pliaka V; Kyriakopoulou Z; Tsakogiannis D; Ruether IG; Gartzonika C; Levidiotou-Stefanou S; Krikelis A; Markoulatos P
Eur J Clin Microbiol Infect Dis; 2010 Dec; 29(12):1513-23. PubMed ID: 20820837
[TBL] [Abstract][Full Text] [Related]
17. Elongation activity of poliovirus RNA polymerase derived from Sabin type 1 sequence is not temperature sensitive.
Baker S; Richards OC; Ehrenfeld E
J Gen Virol; 1995 Aug; 76 ( Pt 8)():2081-4. PubMed ID: 7636491
[TBL] [Abstract][Full Text] [Related]
18. Mutations in Sabin 2 strain of poliovirus and stability of attenuation phenotype.
Rezapkin GV; Fan L; Asher DM; Fibi MR; Dragunsky EM; Chumakov KM
Virology; 1999 May; 258(1):152-60. PubMed ID: 10329577
[TBL] [Abstract][Full Text] [Related]
19. Genetic basis of attenuation of the Sabin oral poliovirus vaccines.
Minor PD; Macadam AJ; Stone DM; Almond JW
Biologicals; 1993 Dec; 21(4):357-63. PubMed ID: 8024751
[No Abstract] [Full Text] [Related]
20. Cell clones cured of persistent poliovirus infection display selective permissivity to the wild-type poliovirus strain Mahoney and partial resistance to the attenuated Sabin 1 strain and Mahoney mutants.
Calvez V; Pelletier I; Couderc T; Pavio-Guédo N; Blondel B; Colbère-Garapin F
Virology; 1995 Oct; 212(2):309-22. PubMed ID: 7571400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
